prof. RNDr. Michal Masařík, Ph.D.
Head of the research group, Michal Masařík Research Group: Cancer Research Lab
Office: bldg. A20/214
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 3631 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 362
2022
-
Advances in Cancer Metabolism and Tumour Microenvironment
Year: 2022, type: Article in Periodical (without peer review)
-
BIOIMAGING OF ELEMENTS AND PROTEINS BY LA-ICP-MS IN MEDICINE AND PHARMACEUTICAL RESEARCH
Year: 2022, type: Appeared in Conference without Proceedings
-
Cancer cell viscoelasticity measurement by quantitative phase and flow stress induction
Biophysical Journal, year: 2022, volume: 121, edition: 9, DOI
-
IMAGING OF ELEMENTS AND PROTEINS IN BIOLOGICAL TISSUES: MEDICAL AND PHARMACEUTICAL APPLICATIONS
Year: 2022, type: Appeared in Conference without Proceedings
-
Metabolic tricks of cancer cells
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, year: 2022, volume: 1877, edition: 3, DOI
-
Metabolická plasticita nádorových buněk
Klinická onkologie, year: 2022, volume: 35, edition: 3, DOI
-
mRNA Subtype of Cancer-Associated Fibroblasts Significantly Affects Key Characteristics of Head and Neck Cancer Cells
Cancers, year: 2022, volume: 14, edition: 9, DOI
-
New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity
Pharmaceutics, year: 2022, volume: 14, edition: 8, DOI
-
Non-psychotropic cannabinoids as inhibitors of TET1 protein
Bioorganic Chemistry, year: 2022, volume: 124, edition: July 2022, DOI
-
Pentamethinium salts suppress key metastatic processes by regulating mitochondrial function and inhibiting dihydroorotate dehydrogenase respiration
Biomedicine & Pharmacotherapy, year: 2022, volume: 154, edition: October 2022, DOI